Transparency Market Research has published a new market report titled, “Single-use Bioprocessing Systems Market: (By Product – Bioreactors & Fermenters, Mixers, Bags, Bioprocess Containers, Filtration Devices, Tubing, Sampling Systems, Connectors & Clamps, Probes & Sensors; By End-user – Pharmaceutical, Biotechnology, CRO & CMO, and Academic & Research Institutes; By Application – Monoclonal Antibody Production, Vaccine Production, Plant Cell Cultivation, Patient Specific Cell Therapies, and Others) – Global & North America Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024.” According to the report, the global single-use bioprocessing systems market was valued at US$ 2,356.8 Mn in 2015 and is projected to expand at a CAGR of 11.1% from 2016 to 2024 to reach US$ 5,914.6 Mn in 2024. This report offers a thorough understanding of the global single-use bioprocessing systems market, its key trends, drivers, restraints, opportunities and threats.
Download Exclusive Global Strategic Business Report:
Single-use bioprocessing systems are disposable equipment and consumables used in research and development as well as commercial production of biological drugs and metabolites. The adoption of single-use bioprocessing systems has seen a paradigm shift in recent years compared to its market over a decade ago. This implies that until recently, bio-production facilities relied on the use of fixed and non-portable stainless steel equipment such as large bioreactors and tanks to culture large volumes of fluid and hold buffers. However, currently, there is a growing acceptance of single-use technologies across the manufacturing process. Technological developments have enabled continuous single-use manufacturing a possibility, driven by the fact that several features of single-use bioprocessing products are continually evolving and improving.
In terms of market share, North America and Europe dominated the single-use bioprocessing systems market in 2015 and are projected to retain their dominant position during the forecast period from 2016 to 2024. This leadership position can be attributed to the fact that CRO’s & CMO’s, and niche biotechnology and multiproduct biopharmaceutical organizations in this region have been early adopters of single-use technologies compared to their counterparts in the emerging markets. The leadership in terms of revenue share is likely to sustain due to cutting edge research and development in biologics being centered in these regions globally. It has been postulated that the purchase of single-use systems would be higher in regions which lay greater emphasis on innovation and in regions where developments in bioscience are clustered. Moreover, many leading vendors are headquartered in North America and Europe, where they have higher share of product sales. Of the top 10 best-selling biological drugs of 2014, five were monoclonal antibodies, four were recombinant proteins, and one was a vaccine. This trend directly percolates to the application segment of the single-use bioprocessing systems market. For instance, in 2015, the highest revenue gaining application segment in both Europe as well as North America was monoclonal antibodies production followed by ‘others’ segment which includes recombinant proteins and enzymes. Together, these segments accounted for over 67% share in North America and over 71% share in Europe of the single-use bioprocessing systems market in 2015.
The pharmerging region of Asia Pacific has a booming biotechnology and biopharmaceutical industry. Moreover, many pharmaceutical organizations are providing contract research services to CRO’s & CMO’s in India and China. Furthermore, many countries in Asia Pacific have a higher cancer and infectious disease burden than the developed world, which implies that the disease burdened population is at a higher need for new cancer therapies and vaccines. Single-use bioprocessing systems will aid to address the unmet needs for a population which requires medicines that are cheaper and take reduced time to market. Driven by the booming biopharmaceutical and contract manufacturing sector and coupled with greater therapeutic needs of the population, the single-use bioprocessing systems market in Asia Pacific is set to expand at a rate higher than the global average during the forecast period from 2016 to 2024. This is attributable to the market seeing an influx of single-use vendors opening offices in countries in Asia Pacific for enhancing business in this region. For instance, in January 2015, Finesse Solutions opened a subsidiary office in Shanghai to serve the active Chinese market for single-use bioprocessing systems, as well as serve major areas of biotech expansion such as Seoul, Tokyo, and Singapore.
Collectively, Latin America and Middle East & Africa contributed to over 23% of the global market share for single-use bioprocessing systems in 2015. The market in these regions has not yet picked up pace as Europe, North America, and Asia Pacific; however, the proximity to North America coupled with increase in contract manufacturing activities is expected to drive the rise in adoption of single-use bioprocessing systems in these markets. A gradually rising biotechnology sector in the UAE as well as South Africa would propel the market for single-use technologies in these countries. However, a skills gap exists in these countries due to which the adoption of single-use technologies may face a restraint during the forecast period. Overall, the MEA and LATAM markets are likely to grow at a rate less than the global average due to late adoption of single-use systems. Despite this, the benefit of cost savings and rapid research would augment market growth in these regions during the period from 2016 to 2024.
Thermo Fisher Scientific, Merck KGaA (Merck Millipore), Danaher Corporation (Pall Corporation), Sartorius AG, Eppendorf AG, GE Healthcare, PBS Biotech, Inc., Meissner Filtration Products, Inc., Finesse Solutions, Sentinel Process Solutions, and Saint-Gobain are the key players operating in this market.
Browse Full Research Report on Single-use Bioprocessing Systems Market:
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.